Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) announced that its Founder and CEO, Payton Nyquvest, will participate in a Water Tower Research Fireside Chat on October 13, 2022, at 2:30 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) announced that its Founder and CEO, Payton Nyquvest, will participate in a Water Tower Research Fireside Chat on October 13, 2022, at 2:30 p.m. ET. The discussion will center around Numinus' strategic acquisition of Novamind and the growth opportunities it presents. Investors can register here.
Details
News Market Reaction – NUMIF
The recorded move for NUMIF in the trading session of this news was -2.44%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
VANCOUVER, BC, Oct. 7, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that Payton Nyquvest, Founder and CEO of Numinus, will participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022, at 2:30 p.m. ET / 11:30 a.m. PT.
The discussion will focus on Numinus' recently completed and transformative acquisition of Novamind; the value this acquisition brings to the Company; and key growth opportunities and catalysts for Numinus.
For all investors and other persons interested in participating, please register here.
For more information about the conference, or to schedule a one-on-one meeting with Numinus' management, please send an email to KCSA Strategic Communications NuminusIR@kcsa.com.
Numinus Wellness (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model - including psychedelic production, research and clinic care - is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at www.numinus.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.
Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.
View original content:https://www.prnewswire.com/news-releases/numinus-to-participate-in-a-water-tower-research-fireside-chat-on-thursday-october-13-2022-301643497.html
SOURCE Numinus Wellness Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.